Yukio Maruyama1, Masaaki Nakayama2, Atsushi Ueda3, Mariko Miyazaki4, Takashi Yokoo1. 1. Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. 2. Kidney Center, St Luke's International Hospital, Tokyo, Japan. 3. Department of Nephrology, Hitachi General Hospital, Ibaraki, Japan. 4. Research Division of Chronic Kidney Disease and Dialysis Treatment, Tohoku University Hospital, Miyagi, Japan.
Abstract
BACKGROUND: Fatigue is one of the most frequent complications in dialyzed patients and is associated with poorer patient outcomes. Multiple factors are reported to be associated with fatigue development. Of them, the impacts of dialysis modalities remain unknown. METHODS: A total of 194 dialysis patients (mean age, 61±11 years; 134 males; modalities included hemodialysis (HD) in 26, online hemodiafiltration (HDF) in 74, peritoneal dialysis (PD) in 68, and combined therapy with PD and HD in 26 cases) were recruited for this cross-sectional study. Fatigue was assessed using the Profile of Mood States (POMS), a Visual Analogue Scale (VAS), and our original scale of fatigue, and depression was assessed by the Beck Depression Inventory-second edition (BDI-II). Our original scale of fatigue was administered both on dialysis and dialysis-free days to patients on HD and online HDF. RESULTS: The scores of the POMS, VAS, and our original scale were weakly but significantly inter-related (rho = 0.58, P<0.01; rho = 0.47, P<0.01, and rho = 0.42, P<0.01 between POMS and VAS, POMS and our original scale for fatigue, and VAS and our original scale for fatigue, respectively). The scores of these 3 tests showed no significant differences among the 4 modalities. On multivariate analysis, age, body mass index, creatinine, and employment status were associated with the presence or severity of fatigue, whereas dialysis modality was not. A similar result was obtained in 122 patients without depression. The prevalence of fatigue by our original scale was significantly lower on dialysis-free days than on dialysis days in patients on HD and online HDF. CONCLUSIONS: The results suggest that there is no significant association between different dialysis modalities including HD, online HDF, PD and combined therapy with PD and HD and the prevalence or severity of fatigue.
BACKGROUND:Fatigue is one of the most frequent complications in dialyzed patients and is associated with poorer patient outcomes. Multiple factors are reported to be associated with fatigue development. Of them, the impacts of dialysis modalities remain unknown. METHODS: A total of 194 dialysis patients (mean age, 61±11 years; 134 males; modalities included hemodialysis (HD) in 26, online hemodiafiltration (HDF) in 74, peritoneal dialysis (PD) in 68, and combined therapy with PD and HD in 26 cases) were recruited for this cross-sectional study. Fatigue was assessed using the Profile of Mood States (POMS), a Visual Analogue Scale (VAS), and our original scale of fatigue, and depression was assessed by the Beck Depression Inventory-second edition (BDI-II). Our original scale of fatigue was administered both on dialysis and dialysis-free days to patients on HD and online HDF. RESULTS: The scores of the POMS, VAS, and our original scale were weakly but significantly inter-related (rho = 0.58, P<0.01; rho = 0.47, P<0.01, and rho = 0.42, P<0.01 between POMS and VAS, POMS and our original scale for fatigue, and VAS and our original scale for fatigue, respectively). The scores of these 3 tests showed no significant differences among the 4 modalities. On multivariate analysis, age, body mass index, creatinine, and employment status were associated with the presence or severity of fatigue, whereas dialysis modality was not. A similar result was obtained in 122 patients without depression. The prevalence of fatigue by our original scale was significantly lower on dialysis-free days than on dialysis days in patients on HD and online HDF. CONCLUSIONS: The results suggest that there is no significant association between different dialysis modalities including HD, online HDF, PD and combined therapy with PD and HD and the prevalence or severity of fatigue.
Authors: Manisha Jhamb; Francis Pike; Sarah Ramer; Christos Argyropoulos; Jennifer Steel; Mary Amanda Dew; Steven D Weisbord; Lisa Weissfeld; Mark Unruh Journal: Am J Nephrol Date: 2011-05-09 Impact factor: 3.754
Authors: Antonio Alberto Lopes; Justin M Albert; Eric W Young; Sudtida Satayathum; Ronald L Pisoni; Vittorio E Andreucci; Donna L Mapes; Nancy A Mason; Shunichi Fukuhara; Björn Wikström; Akira Saito; Friedrich K Port Journal: Kidney Int Date: 2004-11 Impact factor: 10.612
Authors: Manisha Jhamb; Christos Argyropoulos; Jennifer L Steel; Laura Plantinga; Albert W Wu; Nancy E Fink; Neil R Powe; Klemens B Meyer; Mark L Unruh Journal: Clin J Am Soc Nephrol Date: 2009-10-01 Impact factor: 8.237
Authors: Andrew Davenport; Ayman Guirguis; Michael Almond; Clara Day; Joseph Chilcot; Maria Da Silva Gane; Naomi Fineberg; Karin Friedl; Benjamin Spencer; David Wellsted; Ken Farrington Journal: Hemodial Int Date: 2018-02-20 Impact factor: 1.812
Authors: Aminu K Bello; Ikechi G Okpechi; Mohamed A Osman; Yeoungjee Cho; Brett Cullis; Htay Htay; Vivekanand Jha; Muhammad A Makusidi; Mignon McCulloch; Nikhil Shah; Marina Wainstein; David W Johnson Journal: Nat Rev Nephrol Date: 2022-09-16 Impact factor: 42.439